Viewing Study NCT02312258


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-02-24 @ 5:06 AM
Study NCT ID: NCT02312258
Status: COMPLETED
Last Update Posted: 2023-09-21
First Post: 2014-12-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)
Sponsor: Takeda
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-04-09
Start Date Type: ACTUAL
Primary Completion Date: 2019-08-12
Primary Completion Date Type: ACTUAL
Completion Date: 2022-08-26
Completion Date Type: ACTUAL
First Submit Date: 2014-12-05
First Submit QC Date: None
Study First Post Date: 2014-12-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-08-06
Results First Submit QC Date: None
Results First Post Date: 2020-11-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-08-23
Last Update Post Date: 2023-09-21
Last Update Post Date Type: ACTUAL